BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 34623203)

  • 1. Hybrid chitosan-lipid nanoparticles of green tea extract as natural anti-cellulite agent with superior
    Abosabaa SA; Arafa MG; ElMeshad AN
    Drug Deliv; 2021 Dec; 28(1):2160-2176. PubMed ID: 34623203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of fabrication parameters to produce chitosan-tripolyphosphate nanoparticles for delivery of tea catechins.
    Hu B; Pan C; Sun Y; Hou Z; Ye H; Zeng X
    J Agric Food Chem; 2008 Aug; 56(16):7451-8. PubMed ID: 18627163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
    Bagre AP; Jain K; Jain NK
    Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitosan-tripolyphosphate nanoparticles as Arrabidaea chica standardized extract carrier: synthesis, characterization, biocompatibility, and antiulcerogenic activity.
    Servat-Medina L; González-Gómez A; Reyes-Ortega F; Sousa IM; Queiroz Nde C; Zago PM; Jorge MP; Monteiro KM; de Carvalho JE; San Román J; Foglio MA
    Int J Nanomedicine; 2015; 10():3897-909. PubMed ID: 26089666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery.
    Rukmangathen R; Yallamalli IM; Yalavarthi PR
    Drug Dev Ind Pharm; 2019 Aug; 45(8):1342-1350. PubMed ID: 31094571
    [No Abstract]   [Full Text] [Related]  

  • 6. Formulation, characterization and in vitro release study of 5-fluorouracil loaded chitosan nanoparticles.
    Samy M; Abd El-Alim SH; Rabia AEG; Amin A; Ayoub MMH
    Int J Biol Macromol; 2020 Aug; 156():783-791. PubMed ID: 32320805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced dermal delivery of diflucortolone valerate using lecithin/chitosan nanoparticles: in-vitro and in-vivo evaluations.
    Özcan I; Azizoğlu E; Senyiğit T; Özyazıcı M; Özer Ö
    Int J Nanomedicine; 2013; 8():461-75. PubMed ID: 23390364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique.
    Fan W; Yan W; Xu Z; Ni H
    Colloids Surf B Biointerfaces; 2012 Feb; 90():21-7. PubMed ID: 22014934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-Assembled Lecithin/Chitosan Nanoparticles Based on Phospholipid Complex: A Feasible Strategy to Improve Entrapment Efficiency and Transdermal Delivery of Poorly Lipophilic Drug.
    Dong W; Ye J; Wang W; Yang Y; Wang H; Sun T; Gao L; Liu Y
    Int J Nanomedicine; 2020; 15():5629-5643. PubMed ID: 32801706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitosan derivatives as effective nanocarriers for ocular release of timolol drug.
    Siafaka PI; Titopoulou A; Koukaras EN; Kostoglou M; Koutris E; Karavas E; Bikiaris DN
    Int J Pharm; 2015 Nov; 495(1):249-264. PubMed ID: 26341322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulated chitosan-sodium tripolyphosphate nanoparticles for co-encapsulation of ellagic acid and anti-inflammatory peptide: characterization, stability and anti-inflammatory activity.
    Xiong Y; Feng YX; Chang M; Wang Q; Yin SN; Jian LY; Ren DF
    J Sci Food Agric; 2023 May; 103(7):3447-3456. PubMed ID: 36812130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrospray fabrication of doxorubicin-chitosan-tripolyphosphate nanoparticles for delivery of doxorubicin.
    Songsurang K; Praphairaksit N; Siraleartmukul K; Muangsin N
    Arch Pharm Res; 2011 Apr; 34(4):583-92. PubMed ID: 21544723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel chitosan oligosaccharide-based nanoparticles for gastric mucosal administration of the phytochemical "apocynin".
    Anter HM; Abu Hashim II; Awadin W; Meshali MM
    Int J Nanomedicine; 2019; 14():4911-4929. PubMed ID: 31456637
    [No Abstract]   [Full Text] [Related]  

  • 14. Preparation of chitosan-TPP microspheres as resveratrol carriers.
    Cho AR; Chun YG; Kim BK; Park DJ
    J Food Sci; 2014 Apr; 79(4):E568-76. PubMed ID: 24621001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel amphiphilic chitosan nanocarriers for sustained oral delivery of hydrophobic drugs.
    Motiei M; Kashanian S
    Eur J Pharm Sci; 2017 Mar; 99():285-291. PubMed ID: 28057549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of 5-Fluorouracil Loaded Chitosan Nanoparticles for Treatment of Skin Cancer.
    Patel G; Yadav BKN
    Recent Pat Nanotechnol; 2020; 14(3):210-224. PubMed ID: 31267881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the potential of lecithin/chitosan nanoparticles in enhancement of antihypertensive efficacy of hydrochlorothiazide.
    Chadha R; Bhandari S; Kataria D; Gupta S; Singh Jain D
    J Microencapsul; 2012; 29(8):805-12. PubMed ID: 22681125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro-in vivo evaluation of chitosan-PLGA nanoparticles for potentiated gastric retention and anti-ulcer activity of diosmin.
    Abd El Hady WE; Mohamed EA; Soliman OAE; El-Sabbagh HM
    Int J Nanomedicine; 2019; 14():7191-7213. PubMed ID: 31564873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coating with tripolyphosphate-crosslinked chitosan as a novel approach for enhanced stability of emulsomes following oral administration: Rutin as a model drug with improved anti-hyperlipidemic effect in rats.
    Asfour MH; Salama AAA
    Int J Pharm; 2023 Sep; 644():123314. PubMed ID: 37579826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chitosan-tripolyphosphate nanoparticles: Optimization of formulation parameters for improving process yield at a novel pH using artificial neural networks.
    Hashad RA; Ishak RA; Fahmy S; Mansour S; Geneidi AS
    Int J Biol Macromol; 2016 May; 86():50-8. PubMed ID: 26783636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.